220 related articles for article (PubMed ID: 2161228)
1. Enzyme interactions of 2,10-ethanoandrostene-3,17-dione: aromatase and 17 beta-hydroxysteroid dehydrogenase.
Greway AT; Mentzer M; Levy MA
Biochem Int; 1990; 20(3):591-7. PubMed ID: 2161228
[TBL] [Abstract][Full Text] [Related]
2. Substituted C19 steroid analogs as inhibitors of aromatase.
Brueggemeier RW; Snider CE; Counsell RE
Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
[TBL] [Abstract][Full Text] [Related]
3. Gas chromatography-mass spectrometric study of 19-oxygenation of the aromatase inhibitor 19-methylandrostenedione with human placental microsomes.
Numazawa M; Nagaoka M; Handa W; Yamada A
Biol Pharm Bull; 2006 Jun; 29(6):1242-5. PubMed ID: 16755025
[TBL] [Abstract][Full Text] [Related]
4. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
[TBL] [Abstract][Full Text] [Related]
5. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
Swinney DC; Watson DM; So OY
Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
Abul-Hajj YJ; Liu XP; Hedge M
Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717
[TBL] [Abstract][Full Text] [Related]
8. Aromatase-inhibitors of the androstenedione-type activate the 17 beta-hydroxysteroid-dehydrogenase in the rat testis tissue suspension model.
Schröder H; Ziegler M; el Etreby MF
J Steroid Biochem; 1988 Oct; 31(4B):685-90. PubMed ID: 3199812
[TBL] [Abstract][Full Text] [Related]
9. Effect of ketoconazole on placental aromatase, 3 beta-hydroxysteroid dehydrogenase-isomerase and 17 beta-hydroxysteroid dehydrogenase.
Ayub M; Stitch SR
J Steroid Biochem; 1986 Dec; 25(6):981-4. PubMed ID: 3025521
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
Numazawa M; Mutsumi A; Tachibana M
Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
Numazawa M; Oshibe M; Yamaguchi S; Tachibana M
J Med Chem; 1996 Mar; 39(5):1033-8. PubMed ID: 8676338
[TBL] [Abstract][Full Text] [Related]
12. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
Osawa Y; Osawa Y; Coon MJ
Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
[TBL] [Abstract][Full Text] [Related]
14. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
[TBL] [Abstract][Full Text] [Related]
15. The effect of epitestosterone on estrogen biosynthesis in vitro.
Bicíková M; Klak J; Hill M; Stárka L
Horm Metab Res; 2000 Apr; 32(4):125-8. PubMed ID: 10824706
[TBL] [Abstract][Full Text] [Related]
16. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
Johnston JO; Wright CL; Holbert GW; Benson HD
J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 2,2-dimethyl-4-hydroxy-4-androstene-3,17-dione as an inhibitor of aromatase.
Furth PS; Rosenberger J; Marcotte PA; Robinson CH
J Enzyme Inhib; 1990; 4(2):131-5. PubMed ID: 2098519
[TBL] [Abstract][Full Text] [Related]
18. Tritium release from [19-3H]-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase.
Furth PS; Robinson CH
Biochemistry; 1989 Feb; 28(3):1254-9. PubMed ID: 2653438
[TBL] [Abstract][Full Text] [Related]
19. 6beta,19-Bridged androstenedione analogs as aromatase inhibitors.
Komatsu S; Yaguchi A; Yamashita K; Nagaoka M; Numazawa M
Steroids; 2009 Nov; 74(12):884-9. PubMed ID: 19524602
[TBL] [Abstract][Full Text] [Related]
20. Biological characterization of A-ring steroids.
Johnston JO; Wright CL; Burkhart JP; Peet NP
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
